Abstract:The three types of peroxisome proliferator-activated receptors (PPAR), termed alpha, delta (or beta), and gamma, belong to the nuclear receptor superfamily. Although peroxisome proliferators, including fibrates and fatty acids, activate the transcriptional activity of these receptors, only prostaglandin J2 derivatives have been identified as natural ligands of the PPAR gamma subtype that also binds thiazolidinedione antidiabetic agents with high affinity. PPARs heterodimerize with retinoic X receptor (RXR) and alter the transcription of target genes after binding to response elements or PPREs, consisting of a direct repeat of the nuclear receptor hexameric DNA recognition motif (PuGGTCA) spaced by 1 nucleotide (DR-1). Upon activation by fatty acids (FAs) and drugs that affect lipid metabolism, PPARs control the expression of genes implicated in intra- and extracellular lipid metabolism, most notably those involved in peroxisomal beta-oxidation. PPARs partially mediate the inductive effects of fibrates and fatty acids on high density lipoprotein (HDL) cholesterol levels by regulating the transcription of the major HDL apolipoproteins, apoA-I and apoA-II. The hypotriglyceridemic action of fibrates and certain fatty acids also involves PPAR and is constituted of: 1) increased hydrolysis of plasma triglycerides due to induction of LPL and reduction of apoC-III expression; 2) stimulation of cellular fatty acid uptake and conversion to acyl-CoA derivatives due to increased expression of genes for fatty acid transport protein and acyl-CoA synthetase; 3) increased peroxisomal and mitochondrial beta-oxidation; and 4) decreased synthesis of fatty acids and triglycerides and decreased production of very low density lipoprotein (VLDL). Hence, both enhanced catabolism of triglyceride-rich particles and reduced secretion of VLDL particles contribute to the hypolipidemic effect of fibrates and fatty acids. Finally, PPARs appear to be involved in differentiation processes because activation of PPAR gamma 2 triggers adipocyte differentiation and stimulates expression of several genes critical to adipogenesis. It is suggested that PPARs are key messengers responsible for the translation of nutritional and pharmacological stimuli into changes in gene expression and differentiation pathways.

Effectiveness of Natalizumab in Patients with Highly Active Relapsing Remitting Multiple Sclerosis

The Multifaceted Impact of Gallstones: Understanding Complications and Management Strategies

Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.

Recent advances in understanding and managing cholesterol gallstones

Managing Gallstone Disease in the Elderly

Gallstones: Prevention, Diagnosis, and Treatment

Metabolic dysfunction-associated gallstone disease: expecting more from critical care manifestations

The effect of hysterectomy on the risk of an abnormal screening Papanicolaou test result.

In vitro and In vivo Anticancer Effects of the Novel Vitamin E Ether Analogue RRR-α-Tocopheryloxybutyl Sulfonic Acid in Prostate Cancer

Recent advances, novel targets and treatments for cholelithiasis; a narrative review

Antioxidant and angiotension-converting enzyme inhibition capacities of various parts of Benincasa hispida (wax gourd).

Effects of general and local anaesthesia on innate and cell-mediated immunity in dogs.

Management of Bile Duct Stones in the Era of Laparoscopic Cholecystectomy

Management of Craniocerebral Trauma and its Relation to Subsequent Seizures

Gallstones in Patients with Chronic Liver Diseases

Hepatolithiasis: Epidemiology, presentation, classification and management of a complex disease

Taken to School: An Interview with the Honorable Judge John E. Jones, III

Management of biliary lithiasis in pregnancy – an updated overview

Combining day patient treatment with family work in a child psychiatry clinic

Gastrointestinal microbiome and cholelithiasis: Current status and perspectives

Overexpression, purification and crystallization of an archaeal DNA ligase from Pyrococcus furiosus.